Maternal antiretroviral use during pregnancy and infant congenital anomalies: the NISDI perinatal study.

@article{Joo2010MaternalAU,
  title={Maternal antiretroviral use during pregnancy and infant congenital anomalies: the NISDI perinatal study.},
  author={Esa{\'u} C Jo{\~a}o and Guilherme Amaral Calvet and Margot R Krauss and Laura Freimanis Hance and Javier Ortiz and Silvina A Ivalo and Russell Pierre and Mary Jo T Necesito Reyes and D Heather Watts and Jennifer Suzanne Read},
  journal={Journal of acquired immune deficiency syndromes},
  year={2010},
  volume={53 2},
  pages={176-85}
}
BACKGROUND We evaluated the association between maternal antiretrovirals (ARVs) during pregnancy and infant congenital anomalies (CAs), utilizing data from the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study. METHODS The study population consisted of first singleton pregnancies on study, > or =20 weeks gestation, among women enrolled in NISDI from Argentina and Brazil who delivered between September 2002 and October 2007. CAs… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Similar Papers

Loading similar papers…